Ocular myasthenia gravis
Authors:
- M. Tariq BhattiMBM. Tariq Bhatti
- Robert L. LesserRLRobert L. Lesser
- 1 November 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 23 (6) , 537-542
Abstract
To review ocular myasthenia gravis (OMG), a localized form of myasthenia gravis clinically involving only the extraocular, levator palpebrae superioris, and orbicularis oculi muscles. Ocular manifestations can masquerade as a variety of ocular motility disorders, including central nervous system disorders and peripheral cranial nerve palsies. While sparing the pupils, the diagnosis and management can be challenging. Because several diagnostic and treatment options are available for OMG, clinicians must decide the sequence and combination based on the level of disease activity and patient disability.Keywords
This publication has 65 references indexed in Scilit:
- Treatment of Myasthenia Gravis Based on Its ImmunopathogenesisJournal of Clinical Neurology, 2011
- Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatmentBritish Journal of Ophthalmology, 2005
- Presynaptic Calcium Channels and the Transmitter Release MechanismAnnals of the New York Academy of Sciences, 1993
- Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986)Acta Neurologica Scandinavica, 1989
- Myasthenia Gravis in the County of Viborg, DenmarkEuropean Neurology, 1989
- Myasthenia GravisNew England Journal of Medicine, 1978
- Functional changes in frog neuromuscular junctions studied with freeze-fractureJournal of Neurocytology, 1974
- Cholinergic Receptor Sites in MuscleNature, 1971
- MYASTHENIA GRAVISThe Lancet, 1966
- MYASTHENIA GRAVIS IMMUNOLOGICAL RELATIONSHIP BETWEEN STRIATED MUSCLE AND THYMUSThe Lancet, 1966